IL116895A - Transdermal patch comprising xanomeline - Google Patents

Transdermal patch comprising xanomeline

Info

Publication number
IL116895A
IL116895A IL11689596A IL11689596A IL116895A IL 116895 A IL116895 A IL 116895A IL 11689596 A IL11689596 A IL 11689596A IL 11689596 A IL11689596 A IL 11689596A IL 116895 A IL116895 A IL 116895A
Authority
IL
Israel
Prior art keywords
xanomeline
transdermal patch
transdermal
patch
Prior art date
Application number
IL11689596A
Other languages
English (en)
Other versions
IL116895A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL116895A0 publication Critical patent/IL116895A0/xx
Publication of IL116895A publication Critical patent/IL116895A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11689596A 1995-01-30 1996-01-25 Transdermal patch comprising xanomeline IL116895A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38047895A 1995-01-30 1995-01-30

Publications (2)

Publication Number Publication Date
IL116895A0 IL116895A0 (en) 1996-05-14
IL116895A true IL116895A (en) 2000-08-31

Family

ID=23501315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11689596A IL116895A (en) 1995-01-30 1996-01-25 Transdermal patch comprising xanomeline

Country Status (23)

Country Link
US (1) US5980933A (de)
EP (1) EP0723781A3 (de)
JP (1) JPH10513181A (de)
KR (1) KR19980701730A (de)
AR (1) AR001790A1 (de)
AU (1) AU709379B2 (de)
BR (1) BR9600216A (de)
CA (1) CA2210711A1 (de)
CO (1) CO4700420A1 (de)
CZ (1) CZ240297A3 (de)
EA (1) EA001083B1 (de)
HU (1) HUP9800832A3 (de)
IL (1) IL116895A (de)
NO (1) NO973471L (de)
NZ (1) NZ301197A (de)
PE (1) PE17397A1 (de)
PL (1) PL321686A1 (de)
RO (1) RO117146B1 (de)
TR (1) TR199700711T1 (de)
TW (1) TW304167B (de)
WO (1) WO1996023463A1 (de)
YU (1) YU5196A (de)
ZA (1) ZA96530B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
EP0821954A1 (de) * 1996-08-01 1998-02-04 Eli Lilly And Company Verfahren zur Behandlung von geistiger Zurückgebliebenheit
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
EP0821956A1 (de) * 1996-08-01 1998-02-04 Eli Lilly And Company Verfahren zur Behandlung disruptiver Verhaltensstörungen
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
JP5106715B2 (ja) * 1999-09-24 2012-12-26 アルロン・ジャパン株式会社 Ｌ−アスコルビン酸、ｌ−アスコルビン酸誘導体の皮膚真皮層への放出方法に使用するための組成物
JP3962684B2 (ja) * 2000-11-06 2007-08-22 サムヤン コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
US20070259859A1 (en) * 2006-05-04 2007-11-08 De Bruin Natasja M W J Muscarinic agonists to treat impulse control disorders
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
WO2012094360A2 (en) 2011-01-04 2012-07-12 Gordon Chiu Biotherapeutics for the treatment of infectious diseases
US10195187B2 (en) 2015-03-06 2019-02-05 Chase Pharmaceuticals Corporation Oxybutynin-xanomeline transdermal therapeutic system combinations
EP3347011A4 (de) 2015-09-11 2019-06-19 Chase Pharmaceuticals Corporation Muscarinkombination und deren verwendung zur bekämpfung von hypocholinergen störungen des zentralen nervensystems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
ZA886218B (en) * 1987-08-28 1990-04-25 Lilly Co Eli Permeation enhancement compositions
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
DE3843239C1 (de) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions

Also Published As

Publication number Publication date
PL321686A1 (en) 1997-12-22
WO1996023463A1 (en) 1996-08-08
CZ240297A3 (cs) 1998-04-15
TW304167B (de) 1997-05-01
BR9600216A (pt) 1998-01-06
EP0723781A2 (de) 1996-07-31
IL116895A0 (en) 1996-05-14
HUP9800832A3 (en) 2000-07-28
NO973471D0 (no) 1997-07-28
AR001790A1 (es) 1997-12-10
CA2210711A1 (en) 1996-08-08
CO4700420A1 (es) 1998-12-29
RO117146B1 (ro) 2001-11-30
NZ301197A (en) 1999-09-29
TR199700711T1 (xx) 1998-01-21
EA199700151A1 (ru) 1997-12-30
MX9705723A (es) 1997-11-29
NO973471L (no) 1997-09-19
AU709379B2 (en) 1999-08-26
HUP9800832A2 (hu) 1999-01-28
YU5196A (sh) 1998-08-14
US5980933A (en) 1999-11-09
EA001083B1 (ru) 2000-10-30
KR19980701730A (ko) 1998-06-25
AU4656596A (en) 1996-08-21
PE17397A1 (es) 1997-05-21
ZA96530B (en) 1997-07-23
JPH10513181A (ja) 1998-12-15
EP0723781A3 (de) 1996-08-07

Similar Documents

Publication Publication Date Title
GB2328375B (en) Transdermal patch
AU8452498A (en) Device for treating aneurysms
SG73598A1 (en) Patch panel
EP0943330A4 (de) Pflaster
HUP9900301A3 (en) Hormone patch
IL116895A (en) Transdermal patch comprising xanomeline
ZA985293B (en) Bandages
HUP0000445A3 (en) Flat transdermal medicated self-adhesive patch
ZA9810252B (en) Grip-aid bandage
IL116997A0 (en) Transdermal formulation
AU5095698A (en) Transdermal patch
IL116999A0 (en) Transdermal formulation
AU6657396A (en) Transdermal system
AU6709196A (en) Transdermal patch containing aspirin
GB9708078D0 (en) Bandage
AU5983199A (en) Coumarin-based or melilot-based transdermal plasters
AU2848695A (en) Soil treating device
AU134535S (en) Patch panel
ZA957812B (en) Scopolamine patch
PL321827A1 (en) Transdermal preparation
GB9623637D0 (en) Transdermal patch assembly
EP0821767A4 (de) Befestigungsanordnung
GB9722194D0 (en) Improved films
GB9524865D0 (en) Patch structures for transdermal therapy
AUPM655294A0 (en) Heel protection device

Legal Events

Date Code Title Description
FF Patent granted